Carroll RE - Search Results

1

Phase IIa clinical trial of curcumin for the prevention of colorectal neoplasia.

Carroll RE, Benya RV, Turgeon DK, Vareed S, Neuman M, Rodriguez L, Kakarala M, Carpenter PM, McLaren C, Meyskens FL Jr, Brenner DE. Carroll RE, et al. Cancer Prev Res (Phila). 2011 Mar;4(3):354-64. doi: 10.1158/1940-6207.CAPR-10-0098. Cancer Prev Res (Phila). 2011. PMID: 21372035 Free PMC article. Clinical Trial.

2

Characterization of gastrin-releasing peptide receptors aberrantly expressed by non-antral gastric adenocarcinomas.

Carroll RE, Carroll R, Benya RV. Carroll RE, et al. Among authors: carroll r. Peptides. 1999;20(2):229-37. doi: 10.1016/s0196-9781(98)00164-8. Peptides. 1999. PMID: 10422879

3

Contribution of gastrin-releasing peptide and its receptor to villus development in the murine and human gastrointestinal tract.

Carroll RE, Matkowskyj K, Saunthararajah Y, Sekosan M, Battey JF, Benya RV. Carroll RE, et al. Mech Dev. 2002 May;113(2):121-30. doi: 10.1016/s0925-4773(02)00032-1. Mech Dev. 2002. PMID: 11960700 Free article.

4

Increased frequency of gastrin-releasing peptide receptor gene mutations during colon-adenocarcinoma progression.

Glover SC, Tretiakova MS, Carroll RE, Benya RV. Glover SC, et al. Among authors: carroll re. Mol Carcinog. 2003 May;37(1):5-15. doi: 10.1002/mc.10117. Mol Carcinog. 2003. PMID: 12720295

5

Expression of vitamin D receptor and 25-hydroxyvitamin D3-1{alpha}-hydroxylase in normal and malignant human colon.

Matusiak D, Murillo G, Carroll RE, Mehta RG, Benya RV. Matusiak D, et al. Among authors: carroll re. Cancer Epidemiol Biomarkers Prev. 2005 Oct;14(10):2370-6. doi: 10.1158/1055-9965.EPI-05-0257. Cancer Epidemiol Biomarkers Prev. 2005. PMID: 16214919

6

Allelic loss of the gene for the GPX1 selenium-containing protein is a common event in cancer.

Hu Y, Benya RV, Carroll RE, Diamond AM. Hu Y, et al. Among authors: carroll re. J Nutr. 2005 Dec;135(12 Suppl):3021S-3024S. doi: 10.1093/jn/135.12.3021S. J Nutr. 2005. PMID: 16317164 Free article. Review.

7

Epidermal growth factor receptor signaling is up-regulated in human colonic aberrant crypt foci.

Cohen G, Mustafi R, Chumsangsri A, Little N, Nathanson J, Cerda S, Jagadeeswaran S, Dougherty U, Joseph L, Hart J, Yerian L, Tretiakova M, Yuan W, Obara P, Khare S, Sinicrope FA, Fichera A, Boss GR, Carroll R, Bissonnette M. Cohen G, et al. Cancer Res. 2006 Jun 1;66(11):5656-64. doi: 10.1158/0008-5472.CAN-05-0308. Cancer Res. 2006. PMID: 16740703

8

Aberrant crypt focus size predicts distal polyp histopathology.

Kim J, Ng J, Arozulllah A, Ewing R, Llor X, Carroll RE, Benya RV. Kim J, et al. Among authors: carroll re. Cancer Epidemiol Biomarkers Prev. 2008 May;17(5):1155-62. doi: 10.1158/1055-9965.EPI-07-2731. Cancer Epidemiol Biomarkers Prev. 2008. PMID: 18483337

9

A phase IIa randomized, double-blind trial of erlotinib in inhibiting epidermal growth factor receptor signaling in aberrant crypt foci of the colorectum.

Gillen DL, Meyskens FL, Morgan TR, Zell JA, Carroll R, Benya R, Chen WP, Mo A, Tucker C, Bhattacharya A, Huang Z, Arcilla M, Wong V, Chung J, Gonzalez R, Rodriguez LM, Szabo E, Rosenberg DW, Lipkin SM. Gillen DL, et al. Cancer Prev Res (Phila). 2015 Mar;8(3):222-30. doi: 10.1158/1940-6207.CAPR-14-0148. Epub 2015 Jan 20. Cancer Prev Res (Phila). 2015. PMID: 25604134 Free PMC article. Clinical Trial.

10

Relationship of aging and tobacco use with the development of aberrant crypt foci in a predominantly African-American population.

Moxon D, Raza M, Kenney R, Ewing R, Arozullah A, Mason JB, Carroll RE. Moxon D, et al. Among authors: carroll re. Clin Gastroenterol Hepatol. 2005 Mar;3(3):271-8. doi: 10.1016/s1542-3565(04)00623-8. Clin Gastroenterol Hepatol. 2005. PMID: 15765447

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

111 results

Search Page